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Oligomerization of Rev molecules has been shown to be required for Rev function. In addition to a Western blot assay
monitoring dimer formation, a new in vivo assay analyzing formation of Rev heteromers in the cytoplasm and during
nuclear import is presented here. The oligomerization assay is based upon the ability of Rev mutants with an intact
nuclear localization signal (NLS) to interact specifically with mutants with a defective NLS and translocate such mutants
to the nuclear compartments. Several of the mutants previously reported to be oligomerization defective were found to
mediate nuclear and nucleolar localization of the NLS mutant. The Rev mutant previously named M4 was the only mutant
tested that did not translocate the mutant with a defective NLS to the nucleus. Furthermore, the predominantly cytoplasmic
localization of the M4 mutant suggests that oligomerization is important for effective nuclear import of Rev. q 1997
Academic Press
INTRODUCTION (Malim et al., 1989, 1991; Mermer et al., 1990; Venkatesh
and Chinnadurai, 1990; Hope et al., 1991, 1992; Weichsel-
The expression of the HIV-1 structural proteins en- braun et al., 1992). Mutations of essential amino acids
coded by unspliced and incompletely spliced HIV-1 within this domain generate trans-dominant negative mu-
mRNAs has been shown to be dependent upon the Rev tants of Rev that inhibit the nuclear export of coexpressed
protein at one or several steps between transcription and wild-type Rev in a dose-dependent manner (Szilvay et
translation. Specific binding of Rev to the Rev-responsive al., 1995; Stauber et al., 1995). One explanation for the
element (RRE) within the unspliced and single spliced effect of trans-dominant negative mutants is the forma-
viral mRNAs and the Rev-dependent appearance of these tion of functionally inactive and export-deficient hetero-
HIV mRNAs in the cytoplasm are two well-established mers with wild-type Rev (Hope et al., 1992; Szilvay et al.,
aspects of Rev regulation (Haseltine, 1991; Cullen, 1992; 1995; Stauber et al., 1995). Multimer formation of Rev
Green, 1993; Cullen, 1995). The discovery that Rev is molecules has been shown to occur both in vitro (Olsen
a nucleocytoplasmic shuttle protein (Meyer and Malim, et al., 1990; Malim and Cullen, 1991; Zapp et al., 1991)
1994; Kalland et al., 1994) suggests that following nuclear and in vivo (Hope et al., 1992; Kubota et al., 1992; Bogerd
import Rev binds to the RRE and carries the RRE-con- and Greene, 1993; Madore et al., 1994) and this capacity
taining RNAs to the cytoplasm. Site-directed mutagene- appears to be critical for Rev function. Several inactive
sis of the 116 amino acid Rev protein has defined two Rev mutants have previously been shown to be defective
functional domains and additional regions necessary for
of oligomerization. Mutations of amino acids in the N-
function. A basic domain (aa 35–50) is responsible for
terminal region (Hope et al., 1992), in the basic domain
the nuclear and nucleolar localization of Rev as well as
(Zapp et al., 1991) and of amino acids flanking the basic
specific binding of Rev to the RNA-target sequence, RRE
domain (Olsen et al., 1990; Malim and Cullen, 1991; Zapp
(Malim et al., 1989; Cochrane et al., 1990; Hope et al.,
et al., 1991) and also in the activation domain (Bogerd
1990a, 1990b; Olsen et al., 1990; Bo¨hnlein et al., 1991;
and Greene, 1993; Madore et al., 1994) have previously
Kjems et al., 1991; Malim and Cullen, 1991; Zapp et al.,
been shown to interfere with the ability of Rev to oligo-1991; Kjems et al., 1992). The other essential domain (aa
merize. Experimental discrepancies using oligomeriza-73–90) previously named the activation domain, signals
tion-defective mutants led us to reexamine the propensityactive nuclear export of Rev (NES) (Meyer and Malim,
of Rev mutants to oligomerize in a novel in vivo assay.1994; Szilvay et al., 1995; Wolff et al., 1995; Fischer et al.,
The assay monitors heteromer formation of Rev mutants1995). This domain is necessary for Rev function in vivo
in the cytoplasm and during nuclear import in transfected
cells. Several mutants previously reported not to oligo-
merize formed heteromers according to the new assay.1 To whom correspondence and reprint requests should be ad-
dressed. Homodimerization of the mutants was examined using a
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Western blot-based assay. With one exception, the re- natively in 4% paraformaldehyde in PBS for 20 min before
replacement of the paraformaldehyde with ice-cold meth-sults obtained by the two assays were consistent, as the
mutants able to form heteromers in the cytoplasm of anol. The coverslips were stored in methanol at 0207
until examination by indirect immunofluorescence. Theexpressing cells were also detected as homodimers in
the Western blot assay. Moreover, the mutants unable anti-Rev MAbs 8E7 and 1G7 have previously been de-
scribed (Kalland et al., 1994a). In short, the MAb 8E7to form homo- or multimers were correspondingly ineffec-
tive in nuclear accumulation. binds to the activation domain of Rev and consequently
does not recognize the Rev mutants TD, M4TD, M6TD,
and M7TD. The MAb 1G7 binds to an epitope in the C-MATERIALS AND METHODS
terminal region that is deleted in the Rev mutant D12/
Plasmids and transfection of COS cells 14. The epitopes of the two MAbs are indicated in Fig.
1. This allowed for detection of one mutant alone whenThe plasmids M4, M5, M6, M7, D12/14, and D18/23
expressed together with another mutant not recognizedencoding rev cDNA mutants under control of the CMV
by the same antibody. In certain combinations, two differ-immediate-early promoter and with the SV40 ori were
ent mutants were simultaneously detected in the samekindly provided by B. Cullen and M. Malim (Malim et al.,
cell using the two different monoclonal antibodies. The1989, 1991). M6 and M5 contains mutations in the basic
immunofluorescence assay was performed as previouslydomain mediating nuclear and nucleolar localization and
described (Kalland et al., 1994a, Szilvay et al., 1995). ForRNA binding, while M4 and M7 are mutated in the re-
concurrent application of the anti-Rev MAbs 8E7 (IgG2a)gions flanking the basic domain affecting amino acid
and 1G7 (IgG2b) isotype-specific Biotin-labeled anti-residues 23, 25, 26, and amino acid residues 54–56,
mouse IgG2b (Southern Biotechnical) combined withrespectively (Malim et al., 1989). The mutant D12/14, in
FITC-labeled Streptavidin (Pierce) and Texas red anti-which amino acid residues 100–112 are deleted, has
mouse IgG2a conjugates (Southern Biotechnical) wereRev wild-type activity (Malim et al., 1989) and the same
used. The anti-Tat MAb 1D9 (IgG1) has been previouslyintracellular localization pattern as the wild-type protein.
described (Marasco et al., 1994). For detection of 8E7Amino acid residues 76–84 are deleted in the trans-
together with 1D9, Texas red anti-mouse IgG2a togetherdominant negative mutant D18/23 (Malim et al., 1991).
with FITC-labeled anti-mouse IgG1 (Southern Biotechni-The mutant D18/23 is referred to as TD in this study. In
cal) were utilized. The samples were viewed at a magnifi-order to delete the epitope for the anti-Rev MAb 8E7 in
cation of 4001 using Nikon Microphot-SA with Epi-Fluo-the mutants M4, M6, and M7 the double mutants M4TD,
rescence. Microscopic images were captured by a colorM6TD, and M7TD were created. The unique BamHI site
camera (Hamamatsu 3 chips chilled CCD camera withbetween the M4, M6, and M7 mutations and the se-
a Hamamatsu C5810 controller unit) and transferred byquence encoding the activation domain was utilized for
a frame grabber to a Power Mac computer where thegeneration of the double mutants. The double mutants
images were stored digitally. The figures were createdwere then made by recombination of the PstI/BamHI frag-
using the Adobe Photoshop program.ments generated by cleavage of the plasmids encoding
M4, M6, or M7 and the trans-dominant negative mutant
Western blot analysisD18/23 (TD). The sequences of the new double mutants
were confirmed by dideoxynucleotide sequencing. An Western blot analysis was performed as previously
overview of the different mutants is shown schematically described using the ECL detection system from Amer-
in Fig. 1 and Table 1. The tat expressor plasmid pExtatIII sham (Szilvay et al., 1995). Transfected cells in 3.5-cm
previously described as pD(83–5365/8033–9296) was dishes were collected in 150 ml lysis buffer (10 mM Tris–
provided by J. Sodroski (Sodroski et al., 1985). COS cells HCl, pH 7.4, 10 mM NaCl, 1.5 mM MgCl2 , and 0.5% NP-
were transfected by the lipofectamine procedure of 40) before addition of 50 ml 41 Sample buffer containing
Gibco BLR using 7 ml lipofectamine per 3.5-cm dish. The 8% SDS and no reducing agents. Prestained low molecu-
following amounts of plasmid DNA per 3.5-cm dish were lar weight standards from Bio-Rad (U.S.A.) and recombi-
utilized: TD and D12/14, 1 mg; M7, 2 mg; M7TD, 3 mg; nant Rev protein from Intracell (U.S.A.) were used as
pExtatIII, M4, M6, M4TD, and M6TD, 5 mg. standards.
Immunofluorescence assay and monoclonal RESULTS
antibodies
Intracellular distribution of Rev mutants
For the immunofluorescence assay the cells were
seeded onto 12-mm coverslips in 24-well plates 24 hr Table 1 and Fig. 2 display the intracellular distribution
of the Rev mutants employed in this study. The Rev mu-after transfection. The coverslips were fixed 48 hr after
transfection either directly in ice-cold methanol or alter- tants M6 and M6TD with mutations and a deletion in the
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TABLE 1
Rev Mutants
Oligomerization Intracellular distribution
Mutant Mutations Biological activity Previous studies Present study Cyt Np No No-Fr.
M4 Y23D, S25D, N26L Neg (1) Neg (2,3,5) Neg // / / 0
M5 R38D, R39L Neg (1) Neg (3) Pos /// { 0 0
Pos (4)
M6 R41D, R44L Neg (1) Neg (3) Pos /// { 0 0
D42– 43
M7 D54, D56 Neg (1) Neg (2,3,4) Pos / // // /
Pos (5)
D12/14 S99D, D100 – 112, G113L WT (1) NT Pos / // /// //
D18/23  TD L75D, D76– 85, N86L TD (6) NT Pos { /// /// ///
M4TD M4 / TD Neg // / // 0
M6TD M6 / TD Pos /// 0 0 0
M7TD M7 / TD Pos / // /// //
Note. Neg, Negative; Pos, Positive; TD, trans-dominant negative; WT, wild-type; NT, not tested; Cyt, cytoplasm; Np, nucleoplasm; No, nucleoli;
No-Fr, nucleolar fragmentation; D, deleted. {, /, //, ///, levels of compartmental expression; 0, not detected. References: (1) Malim et al.,
1989; (2) Malim and Cullen, 1991; (3) Zapp et al., 1991; (4) Madore et al., 1994; (5) Bogerd and Green, 1993; (6) Malim et al., 1991.
basic domain remained in the cytoplasm of expressing Assay for nuclear import of a Rev mutant with
defective nuclear and nucleolar localization signalscells (Figs. 2A and 2B). A weak diffuse staining of the
nucleoplasm probably caused by diffusion of Rev mole-
Cotransfection of M6 and M6TD with the Rev mutants
cules across the nuclear membrane was evident in some
TD and D12/14, respectively, in which the epitopes of
cells. Nucleolar staining was, however, never detected.
either MAb 8E7 or MAb 1G7 are deleted, made it possible
The staining both in the cytoplasm and nucleoplasm ap-
to detect the localization of the import defective mutants
peared stronger when the cells were fixed by paraformal-
only. Nuclear and nucleolar localization of the M6 and
dehyde compared to fixation by methanol. The two mu- M6TD mutant was taken as evidence of heteromerization
tants M4 and M4TD that were mutated in the N-terminal with the coexpressed mutants in the cytoplasm followed
region, exhibited a similar localization pattern with most
of the staining in the cytoplasm, in addition to an even
staining in the nucleoplasm. Accumulation in the nucleoli
was detected in some cells, but this was more noticeable
with the M4TD mutant (Figs. 2C and 2D). The mutant
M7 and the mutant D12/14 both localized to the cellular
compartments previously reported for wild-type Rev (Kal-
land et al., 1994a) with predominant nucleoplasmic and
nucleolar localizations (Figs. 1E and 1G). The nuclear
accumulation of the double mutant M7TD and the TD
mutant were particularly apparent (Figs. 1F and 1H).
When paraformaldehyde was used as a fixative, the
staining of the nucleoli was mainly seen at the periphery
(Figs. 2C–2E and 2G). Using methanol fixation the stain-
ing of the nucleoli was stronger (Figs. 2F and 2H) while
the nucleoplasmic and cytoplasmic staining were
weaker. Corresponding fixation-dependent differences
have been observed with wild-type Rev (V. Andresen, FIG. 1. The Rev protein and the Rev mutants employed in the study
schematically outlined. The sequences mediating nuclear/nucleolar lo-unpublished results). Nuclear overexpression of Rev pro-
calization (NLS/NOS) and nuclear export (NES) are indicated. The epi-teins D12/14, TD, M7, and M7TD was apparent as nucle-
topes of the two anti-Rev MAbs are shown. There is no binding of theolar ballooning or fragmentation of nucleoli accompanied MAb 8E7 to any of the TD mutants. The MAb 1G7 does not bind to the
by accumulation of Rev protein along the nuclear mem- Rev mutant D12/14. The mutations and deletions are indicated in black.
The drawings are not in scale.brane (marked with arrowheads in Figs. 2E through 2H).
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by transport of the heteromer into the nuclear compart-
ments. Detection of M6 by the MAb 8E7 showed that
coexpression of M6 with the TD mutant leads to effective
translocation of M6 into the nucleoplasm and nucleoli
(Fig. 3A). Simultaneous detection of both the M6 and
TD mutants using the MAb 1G7 demonstrated that both
mutants were expressed (Fig. 3B). Note that one of the
cells in Fig. 3B expresses the TD mutant only. Cotrans-
fection of the mutants M6TD and D12/14 allowed for
concomitant detection of each mutant separately using
the MAbs 8E7 and 1G7. Figures 3D and 3E show that
when coexpressed with D12/14 the M6TD mutant was
detected in the nucleoli. Interestingly, at the same time
the cytoplasmic appearance of the mutant D12/14 was
much more dominant than without coexpression of M6TD
(Fig. 3D). The HIV-1 Tat protein accumulating in the
nucleoli may employ the same nuclear import mecha-
nism as Rev (Marasco et al., 1994). Therefore, cotransfec-
tion experiments using a Tat expressor plasmid together
with the M6 mutant were performed in order to exclude
nuclear import of the M6 mutant by a mechanism of
nonspecific interactions. No nuclear or nucleolar local-
ization of M6 was detected in these control experiments
(Fig. 3G).
Evaluation of oligomerization negative Rev mutants
using the new in vivo import assay
The cotransfection assay using Rev mutants previously
described as oligomerization defective together with im-
port defective mutants was employed to test nuclear im-
port of the latter. The M7TD mutant with mutations in
two of the regions previously claimed to be essential for
oligomerization was remarkably efficient in translocating
the M6 mutant to the nucleoplasm and the nucleoli, sug-
gesting formation of heteromers consisting of M6 and
M7TD. Figures 4A and 4B demonstrate the nuclear im-
port of the M6 mutant and colocalization of the two mu-
tants, respectively. Similar experiments with the M4TD
mutant did not, however, result in nuclear import of M6.
Figure 4C shows cytoplasmic localization of the M6 mu-
tant in contrast to the localization of M4TD detected by
the MAb 1G7 in the same cells (Fig. 4D). The failure of
FIG. 2. Intracellular localization of the Rev mutants utilized in this
M4TD to mediate nucleolar import of M6 could be causedstudy. The cells in A, B, C, D, E, and G were fixed using paraformalde-
by less efficient nucleolar import or the low expressionhyde. The cells in F and H were fixed directly in methanol. The anti-
Rev MAbs used for detection and the mutant detected are indicated levels of the M4TD mutant observed. However, cotrans-
in the lower right corner of each panel. The mutants M6 and M6TD with fection experiments using the M4 mutant together with
deletions in the basic domain mediating nuclear/nucleolar localization the TD mutants showed very little, if any, increase in the
were detected in the cytoplasm. A weak nucleoplasmic staining was
amount of nuclear M4 mutant detected (Fig. 4E), indicat-also visible (A and B). The M4 and M4TD mutants localized to the
ing that formation of heteromers involving the mutantscytoplasm, nucleoplasm, and the nucleoli (C and D). Nuclear and nucle-
olar accumulation was the most noticeable pattern of the mutants M7, M4 and TD had not taken place. Figure 4F shows nuclear
M7TD, D12/14, and TD (E throughout H). The arrowheads indicate accumulation of the coexpressed TD mutant detected
cells overexpressing the mutant protein in the nucleus. Phase contrast by MAb 1G7. The localization patterns of another basic
microscopy of these cells showed nucleolar pathogenic changes (not
domain mutant M5, alone and after cotransfection withshown). The individual panels consist of cells collected from different
the mutants TD, M7TD, M4TD and the tat plasmid, weremicroscopic fields presenting the different localization patterns of the
various mutants. similar to those of the M6 mutant (not shown).
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FIG. 3. Heteromerization assay of Rev mutants in the cytoplasm. (A and B) Double-labeling of cells cotransfected with the rev mutants M6 and
TD showing nucleolar import of the M6 mutant. One of the cells in B expresses the TD mutant only. The MAb 8E7 recognizes the M6 mutant only
while the MAb 1G7 detects both mutants. The specificities of the MAbs are indicated in the lower right corner of the panels. (C) Phase contrast
micrograph of the cells in A and B. (D and E) Double-labeling of cells cotransfected with the rev mutants M6TD and D12/14 showing nucleolar
import of the M6TD mutant. The MAb 8E7 recognizes the D12/14 mutant only, while the MAb 1G7 detects the mutant M6TD only as indicated in
the lower right corner of the panels. (F) Phase contrast micrograph of the cells in D and E. (G and H) Double-labeling of cells cotransfected with
the rev mutant M6 and the plasmid encoding the HIV-1 Tat protein. No nucleolar import of M6 is detected. The MAb 8E7 detects the M6 mutant
while the anti-Tat MAb 1D9 detects Tat, as indicated in the lower right corner of the panels. (I) Phase contrast micrograph of the cells in the lower
section of G and H. Arrows in C, F, and I indicate transfected cells. The cells were fixed using paraformaldehyde except for the double-cell in the
upper right corner shown in G and H that was fixed by methanol directly.
Detection of monomers and homo-dimers of Rev Figs. 5B and 5C). The mutant M6 was solely detected as
monomers using the MAb 8E7 (Figs. 5A, lane 1, and 5C,mutants by Western blot analysis of denatured
samples of cell lysates lane 6). The amount of M6 protein in the cell lysates
was evidently much less than the amounts of the other
The results obtained by the in vivo assay testing for
mutants displayed in Fig. 5A. A longer exposure time of
nuclear import of the M6 mutant were unexpectedly con-
the film after ECL development was necessary for the
firmed by Western blot analysis of samples containing a
M6 lane (60 min for lane 1 and 5 min for lanes 2–6 in
final concentration of 2% SDS. Monomers and dimers of
Fig. 5A).
Rev molecules were detected in denatured lysates of
cells transfected with the M7, TD, D12/14 mutants and
DISCUSSION
wild-type Rev (Figs. 5A–5C). The M4 mutant was, how-
ever, detected only as a monomer despite expression Previous studies demonstrated that mutations that
have affected the ability of Rev molecules to oligo-levels of protein comparable to the other mutants (com-
pare Fig. 5A, lane 3, with lanes 2, 4, and 5). No results merize have also inactivated the function of Rev in
parallel assays (Olsen et al., 1990; Malim and Cullen,of dimer formation by Western blot analysis are available
for the mutants M4TD and M6TD since they were ex- 1991; Zapp et al., 1991). The level at which oligomer-
ization is critical for function has not been determined.pressed at levels not detectable by the MAb 1G7. The
affinity of this MAb is lower than that of the MAb 8E7, as Initial data that oligomerization was a prerequisite for
binding of Rev to RRE (Olsen et al., 1990; Zapp et al.,demonstrated by the difference in signal strength when
detecting 25 ng of recombinant Rev (compare lanes 1 in 1991) have been contradicted by later reports (Hope
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Studies of oligomerization of Rev mutants in vitro
led to the conclusion that the regions characterized
by the M4 and M7, or similar mutations flanking the
basic domain, form a bipartite multimerization domain
(Olsen et al., 1990; Malim and Cullen, 1991; Zapp et
al., 1991). The conclusions concerning this domain
became, however, less clear when the M4 and M7
mutants were assayed for oligomerization in the nu-
FIG. 4. The M4 mutation, but not the M7 mutation, compromises
oligomerization. (A and B) Double-labeling of cells cotransfected with
the rev mutants M6 and M7TD showing nucleolar import of M6 in A.
The MAb 8E7 recognizes the M6 mutant only while the MAb 1G7
detects both mutants. This is indicated in the lower right corner of the
panels. (C and D) Double-labeling of cells cotransfected with the rev
mutants M6 and M4TD showing that no change in the localization
pattern of M6 has occurred (C). The MAb 8E7 recognizes the M6 mutant
only while the MAb 1G7 detects both the mutants, as indicated in the
lower right corner of the panels. (E and F) Double-labeling of cells
cotransfected with the rev mutants M4 and TD showing that no change
in the localization pattern of M4 in E had occurred. F shows that the
TD mutant accumulated in the nucleus of the same cells. The MAb
8E7 recognizes the Rev mutant M4 while the MAb 1G7 detects both
the mutants, as indicated in the lower right corner of the panels. The
cells in A and B were fixed in methanol while the cells in C throughout
F were fixed with paraformaldehyde. The individual panels consist of FIG. 5. Western blot analysis of COS cells transfected with the rev
cells collected from different microscopic fields. plasmids indicated above each lane. Cell lysates from two separate
experiments were used in A and B/C, respectively. The cell lysate
samples contained 2% SDS. Purified recombinant Rev protein (25 ng)
et al., 1992; Kubota et al., 1992; Bogerd and Greene, was applied in the Rev standard wells. (A) Rev mutants M4, M6, M7,
1993). Instead, it has been proposed that oligomeriza- and D12/14 detected using the MAb 8E7. The samples were run on
the same gel but intervening lanes were excised. Arrowheads indicatetion of Rev molecules may position individual activa-
monomers and dimers of D12/14 and mixed dimers between D12/14tion domains or leucine-rich domains in order to cre-
and TD (the TD mutant is not detected by 8E7). The molecular weightsate a domain consisting of several leucine-rich re-
of the standard proteins (not shown) are indicated. (B) Detection of Rev
peats required for efficient interaction with a host cell and Rev mutants by the MAb 1G7. The MAb 1G7 detects the Rev
factor (Bogerd and Greene, 1993; Madore et al., 1994; mutants M7, TD, and M7TD and wild-type Rev. (C) Detection of Rev
and the Rev mutants by the MAb 8E7 using the same samples of cellSzilvay et al., 1995; Stauber et al., 1995). The sugges-
lysates as in B. The MAb 8E7 detects the mutants M6 and M7 andtion that formation of mixed oligomers might underlie
wild-type Rev. The mutants TD and M7TD where amino acid residuestrans-dominant inhibition (Hope et al., 1992) and the
76–85 were deleted are not detectable by the MAb 8E7. Because of
finding that trans-dominant negative mutants inhibited the lower affinity of the MAb 1G7 compared to the MAb 8E7 neither
nuclear export of wild-type Rev support this hypothe- dimers of wild-type Rev and M7 nor the mutant M6 was detected by
the MAb 1G7 in B. Monomers and dimers are indicated as M and D.sis (Szilvay et al., 1995; Stauber et al., 1995).
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cleus in vivo (Bogerd and Greene, 1993; Madore et (Meyer and Malim, 1994; Stauber et al., 1995; Szilvay
et al., 1995; Wolff et al., 1995). Nuclear overexpressional., 1994). One of the studies demonstrated loss of
oligomerization caused by the M4 mutation and not of Rev very often leads to destruction of nucleoli re-
sembling the effects caused by actinomycin D treat-by the M7 mutation (Bogerd and Greene, 1993). Ma-
dore et al. analyzed the ability of mutants while bound ment of cells. Such toxic effects were also reported
by Nosaka and co-workers (Nosaka et al., 1993) andto a truncated RRE sequence to interact with the M5
mutant. They found that the M7 mutation inhibited are likely to affect other biological activities, such as
transcription. This suggests an alternative explanationoligomerization while the M4 mutation had less effect
(Madore et al., 1994). Both studies concluded surpris- for the inhibition of the CAT activity in the two studies.
Zapp and co-workers found that mutations that af-ingly that mutations in the leucine-rich activation do-
main abolished (Bogerd and Greene, 1993) or consid- fected RRE binding also abolished formation of homo-
oligomers (Zapp et al., 1991). The immunofluores-erably inhibited oligomerization (Madore et al., 1994).
Of the regions comprising the so-called bipartite oligo- cence import assay presented here detects nuclear
import of the basic domain mutants M6, M6TD (andmerization domain we found that only the M4 mutation
abolished oligomerization. Using the immunofluores- M5) following heteromerization with mutants con-
taining an intact nuclear localization signal. Further-cence import assay presented here, interaction was
detected neither between the M4TD and the M6 mu- more, the assay employed by Madore et al. is based
upon the capacity of the mutant M5 to form heteromerstants (Figs. 4C and 4D) nor between the M4 and TD
mutants (Figs. 4E and 4F). Neither were homodimers (Madore et al., 1994). Using the Western blot assay,
homodimer formation of the M6 mutant was also notof the M4 mutant detected using the Western blot
assay (Fig. 5A, lane 3). Heteromers between the dou- detected in the present study (Fig. 5A, lane 1, Fig. 5C,
lane 6). We have, however, observed both by Westernble mutant M7TD mutated in two of the regions
claimed to be necessary for oligomerization (Madore blot and immunofluorescence analysis that the ex-
pression of the mutants located in the cytoplasm waset al., 1994) and the basic domain mutant M6 was,
however, easily demonstrated by the immunofluores- lower compared to the mutants located specially in
the nucleus. Cytoplasmic degradation of Rev (Kubotacence assay (Figs. 4A and 4B). Hence, in contrast to
both Bogerd and Greene and Madore et al. we found et al., 1996) could account for the apparent low expres-
sion of the cytoplasmic mutants. Since the concentra-efficient heteromerization in the cytoplasm of trans-
fected cells between the mutants where the leucine tion of antigen bound to the nitrocellulose membrane
is one of the limiting factors in Western blot analysis,domains were deleted (TD and M7TD) and the M6
mutant (Figs. 3A, 3B, 4A, and 4B). Likewise, was heter- the failure to detect homodimers of the M6 mutant
could be concentration dependent. The assays em-omerization between the mutants D12/14 and M6TD
demonstrated (Figs. 3D and 3E). Homodimers were ployed in the present study analyze oligomerization
occurring in cells that do not express the target RNA.detected by Western blot analysis of denatured ly-
sates of cells transfected with the M7, TD, and D12/ Thus, it is the intrinsic ability of Rev molecules to form
complexes that has been studied. The results demon-14 mutants and wt Rev (Fig. 5). However, homodimer-
ization seemed to be more efficient with the TD mutant strate that the RRE is neither required for heteromer
formation of wild-type Rev and the mutants M7, M7TD,than with the M7 mutants, M7 and M7TD, since only
homodimers of the TD mutant were detectable by the D12/14, TD, M6, M6TD, and M5 nor for homodimeriza-
tion of the wild-type Rev and the mutants M7, TD, andanti-Rev MAb 1G7 (Fig. 5B). Dimer formation of the
M7 mutant was, nevertheless, demonstrated using the D12/14. The requirements for oligomerization in the
nucleus including binding to the RRE and cellular fac-high affinity anti-Rev MAb 8E7 (Figs. 5A and 5C). Inter-
estingly, by Western blot analysis of cells cotrans- tors may on the other hand involve additional regions
of the Rev molecule. The findings that the localizationfected with D12/14 and TD a new band of slower mi-
gration than the D12/14 dimer band appeared. The pattern of the M6 Rev mutant was not affected by coex-
pression with the Rev mutant M4TD and that the nu-three bands are marked with arrowheads in Fig. 5A.
This band was not visible with only D12/14 present, clear import of the M4 mutant was not increased by
the TD mutant confirm that the N-terminal region of theindicating the appearance of a complex consisting of
the mutants D12/14 and TD. In the assays presented Rev molecule is somehow involved in oligomerization
(Olsen et al., 1990; Malim and Cullen, 1991; Zapp ethere heteromerization was examined during nuclear
import while in the studies by Bogerd and Greene and al., 1991; Hope et al., 1992; Bogerd and Greene, 1993).
Interestingly, the M4 and M4TD mutants containingMadore et al. dimerization was assayed as transcrip-
tion of the CAT gene from a reporter plasmid. We and intact nuclear and nucleolar localization signal still
localized mostly to the cytoplasm (Figs. 2C and 2Dothers have previously reported that trans-dominant
negative mutants of Rev accumulate in the nucleus and Table 1) (Wolff et al., 1995). This suggests that
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Occurs Through Formation of Inactive Protein Complexes. J. Virol.there exists a close correlation between the nuclear
66, 1849–1855.accumulation of the mutants and the ability to form
Hope, T. J., McDonald, D., Huang, X., Low, J., and Parslow, T. G. (1990b).
heteromers and homodimers. Dimerization as a pre- Mutational Analysis of the Human Immunodeficiency Virus Type 1
requisite for nuclear import was moreover, suggested Rev Transactivator: Essential Residues Near the Amino Terminus. J.
Virol. 64, 5360–5366.by Kubota and co-workers (Kubota et al., 1992). The
Kalland, K. H., Szilvay, A. M., Langhoff, E., and Haukenes, G. (1994a).observed effect of mutations in the N-terminal region
Subcellular Distribution of Human Immunodeficiency Virus Type 1could be caused by mutations of amino acid residues
Rev and Colocalization of Rev with RNA Splicing Factors in a Speck-
that partake in the oligomerization as such. Or, the led Pattern in the Nucleoplasm. J. Virol. 68, 1475–1485.
results could be explained by conformational changes Kalland, K. H., Szilvay, A. M., Brokstad, K. A., Sætrevik, W., and
Haukenes, G. (1994b). The human immunodeficiency virus type 1or changes in secondary structure in the Rev molecule
(HIV-1) Rev protein shuttles between the cytoplasm and nuclear com-caused by these mutations thereby impairing the abil-
partments. Mol. Cell Biol. 14, 7436–7444.ity of the mutant to oligomerize and to interact with
Kjems, J., Calnan, B. J., Frankel, A. D., and Sharp, P. A. (1992). Specific
cellular factors mediating nuclear import. Binding of a Basic Peptide From HIV-1 Rev. EMBO J. 11, 1119–1129.
Kjems, J., Frankel, A. D., and Sharp, P. A. (1991). Specific Regulation of
mRNA Splicing In Vitro by a Peptide From HIV-1 Rev. Cell 67, 169–ACKNOWLEDGMENTS
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